Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 6/2020

18.12.2019 | Image of the Month

FDG-PET/CT in the detection of pituitary stalk ACTH-secreting adenoma

verfasst von: Ziren Kong, Yu Wang, Wenbin Ma, Xin Cheng

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Excerpt

A 50-year-old male diagnosed with an adrenocorticotropic hormone (ACTH)–dependent Cushing syndrome, and inferior petrosal sinus sampling displayed an ACTH concentration 4 times higher than that of peripheral blood. MRI demonstrated abnormal signal at posterior pituitary as well as thickening at pituitary stalk. The patient underwent transnasal endoscopic pituitary lesion resection, but immunohistochemistry demonstrated negative ACTH, and no significant clinical improvement was observed. The patient was admitted to our hospital and whole-body FDG-PET/CT was performed. Cranial FDG-PET/CT showed a 0.5 × 0.5-cm lesion at pituitary stalk with radioactivity (SUVmax 3.2, arrow noted), and no abnormal FDG uptake was found in the chest cavity or other part of the body. The patient was considered having a pituitary stalk ACTH-secreting adenoma, and a craniotomy for pituitary stalk lesion was performed. Pathology confirmed ACTH-secreting adenoma (ACTH-positive for immunohistochemistry), and patient displayed significant clinical improvement. …
Literatur
1.
Zurück zum Zitat Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005;90(8):4955–62.CrossRef Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005;90(8):4955–62.CrossRef
2.
Zurück zum Zitat Turcu AF, Erickson BJ, Lin E, et al. Pituitary stalk lesions: the Mayo Clinic experience. J Clin Endocrinol Metab. 2013;98(5):1812–8.CrossRef Turcu AF, Erickson BJ, Lin E, et al. Pituitary stalk lesions: the Mayo Clinic experience. J Clin Endocrinol Metab. 2013;98(5):1812–8.CrossRef
3.
Zurück zum Zitat Ling SY, Zhao ZY, Tao B, et al. Pituitary stalk thickening in a large cohort: toward more accurate predictors of pituitary dysfunction and etiology. Endoc Pract. 2019;25(6):534–44.CrossRef Ling SY, Zhao ZY, Tao B, et al. Pituitary stalk thickening in a large cohort: toward more accurate predictors of pituitary dysfunction and etiology. Endoc Pract. 2019;25(6):534–44.CrossRef
4.
Zurück zum Zitat Xu H, Zhang M, Zhai G, Zhang M, Ning G, Li B. The role of integrated (18)F-FDG PET/CT in identification of ectopic ACTH secretion tumors. Endocrine. 2009;36(3):385–91.CrossRef Xu H, Zhang M, Zhai G, Zhang M, Ning G, Li B. The role of integrated (18)F-FDG PET/CT in identification of ectopic ACTH secretion tumors. Endocrine. 2009;36(3):385–91.CrossRef
5.
Zurück zum Zitat Wang H, Hou B, Lu L, et al. PET/MRI in the diagnosis of hormone-producing pituitary microadenoma: a prospective pilot study. J Nucl Med. 2018;59(3):523–8.CrossRef Wang H, Hou B, Lu L, et al. PET/MRI in the diagnosis of hormone-producing pituitary microadenoma: a prospective pilot study. J Nucl Med. 2018;59(3):523–8.CrossRef
Metadaten
Titel
FDG-PET/CT in the detection of pituitary stalk ACTH-secreting adenoma
verfasst von
Ziren Kong
Yu Wang
Wenbin Ma
Xin Cheng
Publikationsdatum
18.12.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 6/2020
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04655-3

Weitere Artikel der Ausgabe 6/2020

European Journal of Nuclear Medicine and Molecular Imaging 6/2020 Zur Ausgabe